These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28478948)

  • 41. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
    Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-year results.
    Albanese A; Stanhope R
    Horm Res; 1997; 48(4):173-7. PubMed ID: 9378463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences.
    Chatelain P
    Endocr Regul; 2000 Mar; 34(1):33-6. PubMed ID: 10808251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study.
    Tauber M; Berro B; Delagnes V; Lounis N; Jouret B; Pienkowski C; Oliver I; Rochiccioli P
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1179-83. PubMed ID: 12629103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial.
    Renes JS; Willemsen RH; Mulder JC; Bakker-van Waarde WM; Rotteveel J; Oostdijk W; Houdijk EC; Westerlaken C; Noordam C; Verrijn Stuart AA; Odink RJ; de Ridder MA; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):854-61. PubMed ID: 25409576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW; Willemsen RH; van der Kaay DC; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
    Hokken-Koelega A; van Pareren Y; Arends N
    Horm Res; 2005; 64 Suppl 3():95-9. PubMed ID: 16439851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small for gestation and growth hormone therapy.
    Arya AD
    Indian J Pediatr; 2006 Jan; 73(1):73-8. PubMed ID: 16444066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin Sensitivity and β-Cell Function in SGA Children Treated With GH and GnRHa: Results of a Long-Term Trial.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 Feb; 101(2):705-13. PubMed ID: 26653111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
    Jung H; Land C; Nicolay C; De Schepper J; Blum WF; Schönau E
    Eur J Endocrinol; 2009 Feb; 160(2):149-56. PubMed ID: 19039085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amplitude of pubertal growth in short stature children with intrauterine growth retardation.
    Lienhardt A; Carel JC; Preux PM; Coutant R; Chaussain JL
    Horm Res; 2002; 57 Suppl 2():88-94. PubMed ID: 12065935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized GH trial with two different dosages in combination with a GnRH analogue in short small for gestational age children: effects on metabolic profile and serum GH, IGF1, and IGFBP3 levels.
    van der Kaay D; Bakker B; van der Hulst F; Mul D; Mulder J; Schroor E; van Elswijk D; Rowaan I; Willeboer M; de Ridder M; Hokken-Koelega A
    Eur J Endocrinol; 2010 May; 162(5):887-95. PubMed ID: 20176737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Czernichow P; Fjellestad-Paulsen A
    Horm Res; 1998; 49 Suppl 2():23-7. PubMed ID: 9730668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.